{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:25:19Z","timestamp":1785511519409,"version":"3.56.0"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"\n Background<\/jats:title>\n A recent nationwide cohort study reported an unadjusted Hazard Ratio (HR) of 2.714 for Vitiligo incidence following COVID-19 vaccination, indicating a major safety concern. This finding was based on cohorts with an \u2248 11-year age difference, immediately raising critical concerns regarding extreme structural selection and detection bias.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n We hypothesize that this extreme association is an artifact of a fatal methodological flaw, challenging the study\u2019s internal validity and subsequent external validity. We aim to quantitatively separate the HR attributable to the structural age imbalance (HR Structural) from the residual HR (HR Residual), which quantifies the uncorrected methodological failure and residual confounding. We further perform a plausible recalculation of risk to demonstrate the complete collapse of the risk signal upon correcting the methodological failure in the baseline cohort.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We performed a direct age-standardization analysis analysis using the age distribution of the scrutinized study\u2019s cohorts (Vaccinated, mean age = 56.32\u00a0years vs. Non-Vaccinated, mean age = 45.51\u00a0years) and applied established national age-specific Vitiligo incidence rates (IR) from external epidemiology.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The HR Structural was calculated to be 1.2104. The remaining HR Residual of 2.2423 quantifies the uncorrected methodological failure. The NV cohort\u2019s observed incidence rate (0.67\/10,000) was found to be nearly 70% lower than the expected rate (2.2146\/10,000), providing quantifiable evidence of profound non-comparability. The subsequent recalculation of risk, correcting for this baseline failure, reduces the observed HR of = 2.714 to an HR Corrected of 1.0025, thus completely annulling the signal of risk due to vaccination.<\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n The HR = 2.714 of the scrutinized study is an unstable statistical artifact. The overwhelming majority of the observed association is a consequence of a fatal design flaw. The HR Corrected of almost 1 confirms that correcting the methodological error eliminates the risk signal, demonstrating a severe lack of internal and external validity of the original study.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fphar.2025.1754809","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:36:27Z","timestamp":1767854187000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Quantifying structural selection bias in observational cohort data: a ponderation analysis of age - specific incidence rates to inform vaccine safety verification"],"prefix":"10.3389","volume":"16","author":[{"given":"Marco","family":"Roccetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1016\/S2468-2667(24)00026-4","article-title":"Estimating the burden of vitiligo: a systematic review and modelling study","volume":"9","author":"Akl","year":"2024","journal-title":"Lancet Public Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.2307\/144855","article-title":"Wage discrimination: reduced form and structural estimates","volume":"8","author":"Blinder","year":"1973","journal-title":"J. Hum. Resour."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e103690","DOI":"10.7554\/eLife.103690","article-title":"Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in Qatar","volume":"14","author":"Chemaitelly","year":"2025","journal-title":"eLife"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"Elm","year":"2007","journal-title":"PLoS Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(15)60742-5","article-title":"The history and fate of the gold standard","volume":"385","author":"Jones","year":"2015","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/ced\/llad028","article-title":"Incidence of vitiligo in South Korea: a nationwide population-based study from 2003 to 2019","volume":"48","author":"Kang","year":"2023","journal-title":"Clin. Exp. Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.jaci.2024.01.025","article-title":"Autoimmune adverse events after COVID-19 vaccination: a nationwide population-based cohort study in Korea","volume":"153","author":"Kim","year":"2024","journal-title":"J. Alergy Clin. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3349\/ymj.2015.56.3.719","article-title":"Prevalence of vitiligo and associated comorbidities in Korea","volume":"56","author":"Lee","year":"2015","journal-title":"Yonsei Med. J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2307\/2525981x","article-title":"Male-female wage differentials in urban labor markets","volume":"14","author":"Oaxaca","year":"1973","journal-title":"Int. Econ. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/computation13100233","article-title":"Beyond the Gold standard: Linear regression and poisson GLM yield identical mortality trends and deaths counts for COVID-19 in Italy: 2021\u20132025","volume":"13","author":"Roccetti","year":"2025","journal-title":"Computation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1186\/s12889-021-11250","article-title":"Health seeking behavior and associated factors among individuals with cough in Yiwu, China: a population-based study","volume":"21","author":"Sun","year":"2021","journal-title":"BMC Public Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/acps.13827","article-title":"Immortal time bias, confounding by indication, and antidepressant pooling","volume":"152","author":"Terao","year":"2025","journal-title":"Acta Psychiatr. Scand."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1754809\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:36:28Z","timestamp":1767854188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1754809\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":12,"alternative-id":["10.3389\/fphar.2025.1754809"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1754809","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"article-number":"1754809"}}